Celera Licenses Protein IP for Lung Cancer Dx

Date October 30, 2009

sam wrote an intriguing post today on
Here’s a little taster
Celera said today that it has licensed the rights to use Medical Therapies Limited’s patent portfolio for the protein midkine in its lung cancer diagnostics programs.
Under the exclusive license with Sydney-based Medical Therapies, Celera will pay up front and milestone payments and royalties on product sales over the life of the patents. Specific financial details were not disclosed by the firms.

Read the rest of this post here

Category Posted in Research

Leave a Reply

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>